Phase I Trial: T4 Immunotherapy of Head and Neck Cancer

Clinical trial NCT01818323 · UNKNOWN

Trial details

NCT number: NCT01818323
Sponsor: King's College London
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2015-06-01
Primary completion: 2024-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.